Related Experiment Video
Updated: Jun 26, 2026

06:47
Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Beyond Fungitoxicity: Recent Achievements in Targeted Fungicide Discovery
Xiyu Wu1,2, Jianping Lu1,2, Shoucai Ma1
1Xianghu Laboratory, Hangzhou 311231, China.
Journal of Fungi (Basel, Switzerland)
|June 25, 2026
Summary
New fungicide discovery strategies target phytopathogenic fungi by focusing on essential processes, pathogen virulence, or host defenses. These precision approaches aim for more selective and sustainable agricultural disease control.
Area of Science:
- Agricultural Science
- Plant Pathology
- Mycology
Background:
- Phytopathogenic fungi threaten global agriculture, exacerbated by fungicide resistance and environmental concerns.
- Precision disease control is crucial for enhancing selectivity, durability, and sustainability in crop protection.
Purpose of the Study:
- To review recent advancements in targeted fungicide discovery for phytopathogenic fungi.
- To categorize and compare novel fungicide strategies based on their mechanisms, selectivity, and deployment challenges.
Main Methods:
- Categorization of fungicide strategies into three groups: targeting essential fungal processes, disarming pathogen virulence, and activating host defenses.
- Comparative analysis of strategies regarding mechanistic rationale, selectivity, resistance risk, and field challenges.
- Discussion of enabling technologies like compound repurposing, structural biology, and AI-assisted design.
Main Results:
- Emerging strategies facilitate the discovery of fungicides with improved specificity and disease-control potential.
- Targeted approaches offer promise for more selective and potentially durable solutions against fungal pathogens.
- Integrated application of novel strategies and technologies accelerates target identification and lead optimization.
Conclusions:
- Precision fungicide discovery is essential for sustainable agriculture.
- Novel strategies targeting fungal biology, virulence, or host defense show significant potential.
- Emerging technologies are key to developing next-generation, selective, and durable antifungal agents.
Related Concept Videos
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

